Current situation in the development of a preventive HIV vaccine

Enferm Infecc Microbiol Clin. 2005 Jul:23 Suppl 2:5-24. doi: 10.1016/S0213-005X(05)75156-9.
[Article in English, Spanish]

Abstract

The uncontrolled progression of the AIDS epidemic has made the development of an efficacious human immunodeficiency virus (HIV) vaccine a major objective of scientific research. No effective preventive vaccine against HIV is currently available and sterilizing immunity has not yet been achieved in animal models. This review analyses the major challenges in developing an AIDS vaccine, in particular the mechanisms involved in viral escape from the immune response, and summarizes the results obtained with the different prototypes of therapeutic and preventive vaccines. Finally, social, economic and healthcare aspects of research into HIV vaccines and current controversies regarding the development of clinical trials are discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • AIDS Vaccines* / economics
  • AIDS Vaccines* / immunology
  • Animals
  • Antigenic Variation / genetics
  • Clinical Trials as Topic / standards
  • Clinical Trials as Topic / statistics & numerical data
  • Goals
  • HIV Antibodies / biosynthesis
  • HIV Antibodies / immunology
  • HIV Antigens / genetics
  • HIV Antigens / immunology
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control
  • HIV-1 / genetics
  • HIV-1 / immunology
  • HIV-1 / physiology
  • Humans
  • Immunity, Mucosal
  • Immunodominant Epitopes / immunology
  • Macaca
  • Multicenter Studies as Topic / statistics & numerical data
  • SAIDS Vaccines / immunology
  • Simian Acquired Immunodeficiency Syndrome / prevention & control
  • Simian Immunodeficiency Virus / immunology
  • Simian Immunodeficiency Virus / physiology
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / virology
  • Vaccination / economics
  • Vaccination / ethics
  • Vaccines, Attenuated
  • Vaccines, DNA
  • Vaccines, Inactivated
  • Vaccines, Synthetic
  • Virus Activation
  • Virus Latency

Substances

  • AIDS Vaccines
  • HIV Antibodies
  • HIV Antigens
  • Immunodominant Epitopes
  • SAIDS Vaccines
  • Vaccines, Attenuated
  • Vaccines, DNA
  • Vaccines, Inactivated
  • Vaccines, Synthetic